Using in vitro fibroblast activation assays, we showed that SOX9 upregulation caused excessive migration, FMT, ECM gene expression, and resistance to apoptosis in IPF fibroblasts. The gene discussed is SOX9; the disease is idiopathic pulmonary fibrosis.